Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Asthma
Location: United States, FL
Clinical Trial Details
Research Study Summary
Do you, or does your child have asthma?
This study is a randomized, double-blind, stratified, parallel-group, multicenter study, 26 weeks in duration, that is designed to evaluate the non-inferiority of fluticasone propionate/salmeterol combination versus fluticasone propionate on the composite endpoint of serious asthma outcomes (asthma-related hospitalization, endotracheal intubation, and death) in subjects with asthma. There is no placebo in this clinical research study. There will be no blood draws. Qualified study participants will receive asthma medication and study related medical care for their asthma at no charge. Compensation may be provided for time and travel.
Patient Inclusion Criteria:
- Are 12 years of age or older, have had asthma for at least one year, are receiving asthma treatment, have had asthma bad enough to see a doctor in the last 12 months.
Patient Exclusion Criteria:
- Subject has unstable asthma within 7 days prior to Visit 1, Subject has an acute upper or lower respiratory tract infection at Visit 1, Subject has concurrent chronic respiratory disease, including but not limited to chronic bronchitis, COPD, or emphysema, Subject had greater than 2 hospitalizations for asthma in the 12 months prior to Visit 1, Subject had an asthma exacerbation requiring systemic corticosteroids within 4 weeks of Visit 1 OR more than 4 separate asthma exacerbations in the 12 months prior to Visit 1, Tobacco Use: History of smoking greater than 10 pack-years
To Learn more
Both Male and Female
Date Last Changed:
July 18, 2013
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these